CSL Seqirus, based in Cambridge, MA, is a global company dedicated to safeguarding individuals and communities from influenza through its expertise in pandemic preparedness and extensive research and production capabilities.
As a leading contributor to influenza prevention worldwide, CSL Seqirus is committed to developing and distributing vaccines to lessen the severity and impact of the disease, with a team dedicated to public health protection and fighting against infectious diseases.